AstraZeneca Plc (NASDAQ: AZN)
AstraZeneca Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AstraZeneca Plc Company Info
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
News & Analysis
Is AstraZeneca Stock a Buy?
3 Unstoppable Stocks to Buy Right Now
3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
AstraZeneca just released some encouraging data about its weight loss drug candidates.
3 Magnificent Stocks Under $100 to Buy in November
The price could be right for these stocks.
3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to disrupt themselves.
3 Market-Beating Stocks to Buy for Less Than $100
These stocks are all up more than 20% this year.
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
The winners of today might not compete in the lucrative new segment of tomorrow.
Valuation
Podcast Episodes
Talking About Vaccine News, Oil Predictions, and More
Discover why the stock price movement of AstraZeneca may be misleading.
INDUSTRY FOCUS // Healthcare // 06-29-2016
Digesting how the U.K. decision to exit the EU could affect healthcare stocks here and abroad.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.